文献速递类风湿关节炎

更新并验证风湿病合并症指数以纳入ICD-10-CM诊断代码

Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD-10-CM Diagnostic Codes.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2023-04-17

在多中心前瞻性类风湿关节炎登记队列中,分别基于ICD-9-CM(n=1,068)和ICD-10-CM(n=1,425)定义队列(n=862同时纳入两队列),从关联行政数据收集2年评估期内的合并症信息,生成ICD-10-CM代码列表并比较两版风湿病合并症指数(RDCI)评分。两队列RDCI评分高度一致(ICC 0.71 [95%CI 0.68-0.74]),合并症患病率绝对差异<6%,且较高RDCI评分与随访期间死亡风险增加和功能状态较差相关,含RDCI的模型在功能状态(QIC)和死亡(AIC)上拟合最优。

要点

  • ICD-10-CM版RDCI与ICD-9-CM版评分高度一致,ICC为0.71(95%CI 0.68-0.74)。
  • 两队列合并症患病率相似,绝对差异<6%。
  • 较高RDCI评分与随访期间死亡风险增加和功能状态较差相关。

核心结论

  • 新提出的ICD-10-CM版RDCI代码生成的评分与ICD-9-CM版相当,且对功能状态和死亡具有高度预测能力。
  • 所提出的ICD-10-CM版RDCI代码可用于跨越ICD-10-CM时代的风湿病结局研究。

研究设计与样本

  • 多中心前瞻性类风湿关节炎登记队列研究,定义ICD-9-CM队列(n=1,068)和ICD-10-CM队列(n=1,425),其中n=862同时纳入两队列。
  • 从关联行政数据收集2年评估期内的合并症信息,通过交叉映射和临床专业知识生成ICD-10-CM代码列表。

主要发现

  • ICD-9-CM队列RDCI评分均值±标准差为2.93±1.72,ICD-10-CM队列为2.92±1.74。
  • 同时纳入两队列的个体RDCI评分一致性ICC为0.71(95%CI 0.68-0.74)。
  • 两队列合并症患病率绝对差异<6%。
  • 两队列中较高RDCI评分均与随访期间死亡风险增加和功能状态较差相关。
  • 两队列中含RDCI评分的模型在功能状态(QIC)和死亡(AIC)上拟合最优。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To update and validate the Rheumatic Disease Comorbidity Index (RDCI) utilizing International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes. METHODS: We defined ICD-9-CM (n = 1,068) and ICD-10-CM (n = 1,425) era cohorts (n = 862 in both) spanning the ICD-9-CM to ICD-10-CM transition in a multicenter, prospective rheumatoid arthritis registry. Information regarding comorbidities was collected from linked administrative data over 2-year assessment periods. An ICD-10-CM code list was generated from crosswalks and clinical expertise. ICD-9- and ICD-10-derived RDCI scores were compared using intraclass correlation coefficients (ICC). The predictive ability of the RDCI for functional status and death during follow-up was assessed using multivariable regression models and goodness-of-fit statistics (Akaike's information criterion [AIC] and quasi information criterion [QIC]) in both cohorts. RESULTS: Mean ± SD RDCI scores were 2.93 ± 1.72 in the ICD-9-CM cohort and 2.92 ± 1.74 in the ICD-10-CM cohort. RDCI scores had substantial agreement in individuals who were in both cohorts (ICC 0.71 [95% confidence interval 0.68-0.74]). Prevalence of comorbidities was similar between cohorts with absolute differences <6%. Higher RDCI scores were associated with a greater risk of death and poorer functional status during follow-up in both cohorts. Similarly, in both cohorts, models including the RDCI score had the lowest QIC (functional status) and AIC (death) values, indicating better model performance. CONCLUSION: The newly proposed ICD-10-CM codes for the RDCI-generated comparable RDCI scores to those derived from ICD-9-CM codes and are highly predictive of functional status and death. The proposed ICD-10-CM codes for the RDCI can be used in rheumatic disease outcomes research spanning the ICD-10-CM era.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Dolomisiewicz A, Ali H, Roul P, et al. Updating and Validating the Rheumatic Disease Comorbidity Index to Incorporate ICD-10-CM Diagnostic Codes. Arthritis Care Res (Hoboken). 2023. PMID: 36951260. doi:10.1002/acr.25116

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。